Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

(BHVN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
132.18(c) 135.34(c) 135.99(c) 136.93(c) 135(c) Last
454 481 373 239 573 408 174 949 888 709 Volume
-1.75% +2.39% +0.48% +0.69% -1.41% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 378 M - -
Net income 2021 -803 M - -
Net Debt 2021 388 M - -
P/E ratio 2021 -10,7x
Yield 2021 -
Sales 2022 718 M - -
Net income 2022 -495 M - -
Net Debt 2022 481 M - -
P/E ratio 2022 -18,3x
Yield 2022 -
Capitalization 8 829 M 8 829 M -
EV / Sales 2021 24,4x
EV / Sales 2022 13,0x
Nbr of Employees 825
Free-Float 86,0%
More Financials
Company
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. The Company's glutamate platform includes three clinical-stage product candidates being developed for the treatment of various neurological indications: trigriluzole for the... 
More about the company
Ratings of Biohaven Pharmaceutical Holding Company Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
09/13BIOHAVEN PHARMACEUTICAL : Cantor Fitzgerald Adjusts Biohaven Pharmaceutical Hold..
MT
09/10BIOHAVEN PHARMACEUTICAL : Spotlights nurtec odt (rimegepant), the only dual-ther..
AQ
09/09BIOHAVEN PHARMACEUTICAL : Spotlights Nurtec® ODT (rimegepant), the only dual-the..
PR
08/10BIOHAVEN PHARMACEUTICAL : UBS Downgrades Biohaven Pharmaceutical to Neutral From..
MT
08/10BIOHAVEN PHARMACEUTICAL : Wedbush Adjusts Biohaven Pharmaceutical's Price Target..
MT
08/09BIOHAVEN PHARMACEUTICAL : Management's Discussion and Analysis of Financial Cond..
AQ
08/09BIOHAVEN PHARMACEUTICAL HOLDING CO L : Results of Operations and Financial Condi..
AQ
08/09BIOHAVEN PHARMACEUTICAL : Posts Wider Q2 Loss
MT
08/09BIOHAVEN PHARMACEUTICAL : Earnings Flash (BHVN) BIOHAVEN PHARMACEUTICAL HOLDING ..
MT
08/09BIOHAVEN PHARMACEUTICAL : Reports Second Quarter 2021 Financial Results And Rece..
PR
08/09Biohaven Pharmaceutical Holding Company Ltd. Reports Earnings Results for the..
CI
08/06BIOHAVEN PHARMACEUTICAL : Wedbush Lifts Biohaven Pharmaceutical's Price Target t..
MT
08/03BIOHAVEN PHARMACEUTICAL : Canaccord Genuity Adjusts Biohaven Pharmaceutical's Pr..
MT
07/30BIOHAVEN PHARMACEUTICAL : Nurtec odt signs as official migraine partner of big m..
AQ
07/29BIOHAVEN PHARMACEUTICAL : Nurtec® ODT Signs as Official Migraine Partner of Big ..
PR
More news
News in other languages on BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

- No features available -

More news
Analyst Recommendations on BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
More recommendations
Chart BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Duration : Period :
Biohaven Pharmaceutical Holding Company Ltd. Technical Analysis Chart | BHVN | VGG111961055 | MarketScreener
Technical analysis trends BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 135,00 $
Average target price 135,64 $
Spread / Average Target 0,47%
EPS Revisions
Managers and Directors
Vladimir Coric Chief Executive Officer & Director
James Engelhart Chief Financial Officer & Treasurer
Declan Doogan Independent Chairman
Charles Conway Chief Scientific Officer
Elyse Stock Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.57.51%8 829
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420